The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Caris Life Sciences
Characterizing chromosome 3p/q genes as biomarkers of treatment response in squamous cell carcinoma of the lung and head and neck.
 
Shiruyeh Schokrpur
Consulting or Advisory Role - MJH Life Sciences
 
Sachin Deshmukh
No Relationships to Disclose
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Joanne Xiu
Employment - Caris Life Sciences
 
Carol Quayle
Employment - Caris Life Sciences
 
Farah Rukshana Abdulla
Employment - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Chul Kim
Consulting or Advisory Role - Arcus Biosciences; AstraZeneca; Daiichi Sankyo; Diffusion Pharmaceuticals; Eisai; Janssen; Jazz Pharmaceuticals; Mirati Therapeutics; Novartis; PierianDx; Sanofi
Research Funding - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Debiopharm Group; Genentech/Roche; Janssen; Karyopharm Therapeutics; Novartis; Regeneron
 
Sourat Darabi
Honoraria - OncoLens
Consulting or Advisory Role - Bayer; BostonGene
 
Michael J. Demeure
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Loxo/Lilly; OnCusp Therapeutics; Orphagen Pharmaceuticals; Pfizer; TD2; Theralink
(OPTIONAL) Uncompensated Relationships - transmed7
 
Ari M. Vanderwalde
Employment - Caris Life Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Compugen; Concerto HealthAI; Elsevier; Inivata
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Lilly O. (Inst); Merck (Inst); Millennium (Inst); Replimune (Inst)
 
Trisha Michel Wise-Draper
Stock and Other Ownership Interests - High Enroll
Consulting or Advisory Role - Caris Life Sciences; Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Caris Life Sciences